TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Pharma Inc AS
Closing information (x1000 EUR)
| Closing information | 2019/12 | 2018/12 | 2017/12 |
| Turnover |
15,030
|
12,650
|
11,884 |
| Financial expenses |
1,488
|
1,460
|
1,657 |
| Earnings before taxes |
2,765
|
1,863
|
566 |
| Total assets |
32,792
|
31,462
|
24,068 |
| Current assets |
7,839
|
6,074
|
5,284 |
| Current liabilities |
2,539
|
3,675
|
2,243 |
| Equity capital |
14,104
|
10,751
|
9,270 |
| - share capital |
2,830
|
2,533
|
2,582 |
| Employees (average) | 30 | ||
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Solvency |
43.0%
|
34.2%
|
38.5% |
| Turnover per employee | 396 | ||
| Profit as a percentage of turnover |
18.4%
|
14.7%
|
4.8% |
| Return on assets (ROA) |
13.0%
|
10.6%
|
9.2% |
| Current ratio |
308.7%
|
165.3%
|
235.6% |
| Return on equity (ROE) |
19.6%
|
17.3%
|
6.1% |
| Change turnover |
2,165
|
991
|
-2,681 |
| Change turnover % |
17%
|
8%
|
-18% |
| Chg. No. of employees | -2 | ||
| Chg. No. of employees % | -6% |
Total value of public sale
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.